Add like
Add dislike
Add to saved papers

Exception Status Listing - A Critical Pathway to Heart Transplantation For Adults with Congenital Heart Diseases.

Adults with congenital heart diseases may not be candidates for conventional therapies for ventricular systolic dysfunction including MCS which moves potential heart transplantation recipients to a higher priority listing status. This results in longer wait list times and mortality. Exception status listing allows for one pathway for this complex and anatomically heterogenous group of patients to be listed for heart transplantation at appropriately high listing status. Our study queried the United Network for Organ Sharing (UNOS) registry to evaluate trends in utilization of exception status listing amongst adults with congenital heart diseases awaiting heart transplantation. While uptrend in utilization of exception status listing precedes the new allocation system, it been greatest since change in allocation system. It continues to remain a vital pathway in allowing adults with CHD, whose waitlist mortality is often not adequately characterized using the waitlist status criteria, timely access to heart transplantation.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app